tiprankstipranks
Advertisement
Advertisement
Certara: Capitalizing on Growing Biosimulation Adoption Despite Near-Term Software Headwinds
PremiumRatingsCertara: Capitalizing on Growing Biosimulation Adoption Despite Near-Term Software Headwinds
2M ago
Certara downgraded to Equal Weight from Overweight at Barclays
Premium
The Fly
Certara downgraded to Equal Weight from Overweight at Barclays
2M ago
Certara downgraded to Equal Weight from Overweight at Barclays
Premium
The Fly
Certara downgraded to Equal Weight from Overweight at Barclays
2M ago
Certara downgraded to Hold from Buy at Craig-Hallum
PremiumThe FlyCertara downgraded to Hold from Buy at Craig-Hallum
2M ago
Certara downgraded to Hold from Buy at Craig-Hallum
Premium
The Fly
Certara downgraded to Hold from Buy at Craig-Hallum
2M ago
Certara price target lowered to $8 from $11 at Baird
Premium
The Fly
Certara price target lowered to $8 from $11 at Baird
2M ago
Certara upgraded to Outperform from Market Perform at Leerink
PremiumThe FlyCertara upgraded to Outperform from Market Perform at Leerink
4M ago
Certara price target lowered to $12 from $16 at Morgan Stanley
Premium
The Fly
Certara price target lowered to $12 from $16 at Morgan Stanley
5M ago
Certara price target lowered to $13 from $14 at Barclays
Premium
The Fly
Certara price target lowered to $13 from $14 at Barclays
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100